DWS Health and Wellness Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
DWS Health and Wellness Fund - Class Inst SUHIX
- NAV / 1-Day Return $50.42 / −0.32 %
- Fund Size $274.1M
- Adjusted Expense Ratio 1.040%
- Net Expense Ratio 1.040%
- Fee Level: Distribution Above Average
- Share Class Type Institutional
- Morningstar Category Health
- Equity Style Box (Funds) Large Value
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 0.27%
- Turnover Ratio 2%
Morningstar’s Analysis SUHIX
Will SUHIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.36 | 33M | Healthcare |
Johnson & Johnson | 6.33 | 17M | Healthcare |
Merck & Co Inc | 5.29 | 14M | Healthcare |
UnitedHealth Group Inc | 5.00 | 13M | Healthcare |
AbbVie Inc | 4.91 | 13M | Healthcare |
Thermo Fisher Scientific Inc | 3.76 | 10M | Healthcare |
Amgen Inc | 3.18 | 9M | Healthcare |
AstraZeneca PLC | 2.88 | 8M | Healthcare |
Novartis AG ADR | 2.78 | 7M | Healthcare |
Abbott Laboratories | 2.68 | 7M | Healthcare |